Compass Therapeutics Inc
(CMPX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 850 | 0 | 0 | 0 | 0 |
| Gross Profit | 850 | N/A | N/A | N/A | N/A |
| Operating Expenses | 15,895 | 12,770 | 15,389 | 11,926 | 13,337 |
| Operating Income | -15,045 | -12,770 | -15,389 | -11,926 | -13,337 |
| Other Income | 1,969 | 1,983 | 1,974 | 1,962 | 2,059 |
| Pre-tax Income | -13,076 | -10,787 | -13,415 | -9,964 | -11,278 |
| Net Income Continuous | -13,076 | -10,787 | -13,415 | -9,964 | -11,278 |
| Net Income | $-13,076 | $-10,787 | $-13,415 | $-9,964 | $-11,278 |
| EPS Basic Total Ops | -0.10 | -0.08 | -0.10 | -0.08 | -0.09 |
| EPS Basic Continuous Ops | -0.10 | -0.08 | -0.11 | -0.08 | -0.09 |
| EPS Diluted Total Ops | -0.10 | -0.08 | -0.10 | -0.08 | -0.09 |
| EPS Diluted Continuous Ops | -0.10 | -0.08 | -0.11 | -0.08 | -0.09 |
| EPS Diluted Before Non-Recurring Items | -0.10 | -0.08 | -0.11 | N/A | N/A |
| EBITDA(a) | $-15,306 | $-12,683 | $-15,733 | $-12,246 | $-13,897 |